Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
26
27
28
29
31
Biosensors and Bioelectronics 2021
2021-10-22 - 2021-10-23    
All Day
Biosensors and Bioelectronics 2021 conference explores new advances and recent updated technologies. It is your high eminence that you enhance your research work in this [...]
Petrochemistry and Chemical Engineering
2021-10-25 - 2021-10-26    
All Day
Petro chemistry 2021 directs towards addressing main issues as well as future strategies of global energy industry. This is going to be the largest and [...]
Cardiac Surgery and Medical Devices
2021-10-30 - 2021-10-31    
All Day
The main focus and theme of the conference is “Reconnoitring Challenges Concerning Prediction & Prevention of Heart Diseases”. CARDIAC SURGERY 2020 strives to bring renowned [...]
Events on 2021-10-22
Events on 2021-10-25
Events on 2021-10-30
Articles

Allscripts to install cloud-based chemotherapy prescribing system across SA health sites

cloud-based chemotherapy

Allscripts to install cloud-based chemotherapy prescribing system across SA health sites

The solution will be integrated with the agency’s existing EMR system.

Health IT firm Allscripts has secured a competitive tender to deliver an electronic chemotherapy prescribing system to over 20 SA Health hospitals and care facilities offering cancer treatment services across South Australia.

SA Health mentioned that the system will be planned, designed and implemented over two and a half years with initial deployment starting in mid-2022. It will be integrated with their existing EMR system from Allscripts.

WHY IT MATTERS

The system to be introduced is the iQemo solution by UK-based company iQ Health Tech. According to a press statement, it offers functionalities such as predefined regimens, prescribing, scheduling, dispensing, chemotherapy administration and reporting.

Allscripts ANZ General Manager Todd Haebich added that the ECPS solution helps enhance patient safety through features like comprehensive chemotherapy regimen management, automatic dose calculations, allergy and sensitivity alerting, decision support linked to pathology and toxicity and drug-to-drug interaction support.

The iQemo system will fulfil SA Health’s need for coordinated care of cancer patients and minimise the risk of dosing errors by providing a readable electronic drug administration chart with all drugs displayed in the order based on a treatment protocol.

Moreover, iQemo’s integration with the Allscript Sunrise EMR will enable a “more complete patient record”. The latter is a single-platform acute and ambulatory solution that delivers the most current information to clinicians at point-of-care delivery. Sunrise is currently installed in a number of the state’s public healthcare centres such as Royal Adelaide Hospital, Flinders Medical Centre and The Queen Elizabeth Hospital.

THE LARGER CONTEXT

In 2019, SA Health revamped the EMR system across its facilities following a review that found it failed. The key recommendation of the independent review was to install Allscripts’ Sunrise EMR and Paperless Administration System.

Allscripts EMR was recently rolled out in the emergency department facilities of public health services under the Gippsland Health Alliance in Victoria.

ON THE RECORD

“Allscripts has a detailed understanding of SA Health’s clinical, business and technical environment and will deliver the iQemo solution in partnership with iQemo experts working alongside them from the UK. This approach provides SA Health with the confidence that safe and timely delivery of the iQemo solution will be achieved,” SA Health ECPS Project Director Paul Thomas said.

“The combination of our relationship with iQ Health Tech and the power and capability of Microsoft Azure allow us to deliver an exceptional SaaS product to SA Health that has been tried and tested in the UK and that enhances both efficiency and patient safety associated with the prescribing and administration of chemotherapy,” Allscripts ANZ’s Haebich also stated.